David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.43% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Financials | 8.31% |
| 5 | Healthcare | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
eHealth
EHTH
$38.4M
| $2.7M | ﹤0.01% |
217,760
+200,679
| +1,175% | +$3.46M |
|
2852
CALL
Thomson Reuters
TRI
$46B
| $2.7M | ﹤0.01% |
23,537
| – | – |
|
|
BRACU
2853
DELISTED
Broad Capital Acquisition Corp Unit
BRACU
| $2.69M | ﹤0.01% |
+268,605
| New | +$2.7M |
|
|
LAC
2854
CALL
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $2.69M | ﹤0.01% |
70,000
-80,000
| -53% | -$2.28M |
|
|
TRUE
2855
DELISTED
TrueCar
TRUE
| $2.69M | ﹤0.01% |
680,133
-371,925
| -35% | -$1.31M |
|
2856
PUT
KE Holdings
BEKE
$20.2B
| $2.69M | ﹤0.01% |
217,100
-50,000
| -19% | -$891K |
|
|
CFFSU
2857
DELISTED
CF Acquisition Corp. VII Unit
CFFSU
| $2.68M | ﹤0.01% |
266,667
-133,333
| -33% | -$1.33M |
|
|
LKFT
2858
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
| $2.68M | ﹤0.01% |
43,215
-94,125
| -69% | -$5.76M |
|
2859
MiMedx Group
MDXG
$656M
| $2.68M | ﹤0.01% |
568,864
+113,044
| +25% | +$553K |
|
2860
SeaStar Medical
ICU
$13.6M
| $2.67M | ﹤0.01% |
1,055
+160
| +18% | +$403K |
|
2861
Comscore
SCOR
$78.4M
| $2.67M | ﹤0.01% |
45,855
-3,299
| -7% | -$189K |
|
|
EPZM
2862
DELISTED
Epizyme, Inc
EPZM
| $2.67M | ﹤0.01% |
2,320,698
+2,061,176
| +794% | +$3.36M |
|
2863
Collegium Pharmaceutical
COLL
$786M
| $2.67M | ﹤0.01% |
130,964
+11,659
| +10% | +$220K |
|
|
MODV
2864
DELISTED
ModivCare
MODV
| $2.67M | ﹤0.01% |
23,103
+21,750
| +1,608% | +$2.51M |
|
2865
CALL
Repligen
RGEN
$9.95B
| $2.65M | ﹤0.01% |
14,100
-9,500
| -40% | -$1.8M |
|
|
SGEN
2866
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.65M | ﹤0.01% |
18,413
-42,249
| -70% | -$5.72M |
|
2867
CALL
Marqeta
MQ
$1.71B
| $2.65M | ﹤0.01% |
+60,000
| New | +$2.79M |
|
|
CELL
2868
DELISTED
PhenomeX Inc. Common Stock
CELL
| $2.65M | ﹤0.01% |
+372,309
| New | +$3.08M |
|
|
SQSP
2869
DELISTED
Squarespace, Inc.
SQSP
| $2.64M | ﹤0.01% |
103,161
+69,459
| +206% | +$1.98M |
|
2870
Tronox
TROX
$862M
| $2.64M | ﹤0.01% |
133,346
+59,853
| +81% | +$1.3M |
|
2871
CALL
Labcorp
LH
$27.2B
| $2.64M | ﹤0.01% |
+11,640
| New | +$2.74M |
|
2872
Chubb
CB
$131B
| $2.64M | ﹤0.01% |
12,323
+10,082
| +450% | +$2.05M |
|
|
NGMS
2873
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $2.63M | ﹤0.01% |
170,685
+82,165
| +93% | +$1.72M |
|
|
MBT
2874
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $2.63M | ﹤0.01% |
772,207
+667,104
| +635% | +$4.98M |
|
2875
nLIGHT
LASR
$2.48B
| $2.63M | ﹤0.01% |
151,471
+104,652
| +224% | +$1.97M |
|
Similar funds
David Shaw's Q1 2022 Portfolio in Review
As of Q1 2022, David Shaw held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
David Shaw withdrew a net $10.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Cenovus Energy worth $141M.
- David Shaw's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- David Shaw added most to Starbucks in Q1 2022, an estimated $384M increase.
- David Shaw's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- David Shaw's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- David Shaw opened 934 new positions and closed 805 in Q1 2022.
- David Shaw's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.